Munich, Germany

Marlon Hinner

USPTO Granted Patents = 24 

 

 

Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 45(Granted Patents)


Location History:

  • Freising, DE (2018 - 2021)
  • Munich, DE (2009 - 2024)

Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Certainly! Here is the article about inventor Marlon Hinner:

Title: Innovator Spotlight: Marlon Hinner - Pioneering Advances in Anti-Cancer Therapies

Introduction:

Marlon Hinner, a proficient inventor based in Munich, Germany, has been making waves in the field of biotechnology with his groundbreaking patents and innovative research. With 23 patents to his name, Marlon is at the forefront of developing cutting-edge therapies for the treatment of various diseases, particularly cancer.

Latest Patents:

1. Anti-cancer fusion polypeptide capable of binding both CD137 and glypican-3 (GPC3): Marlon's invention of a fusion polypeptide specific for both CD137 and GPC3 opens up new possibilities in anti-cancer treatment. This fusion polypeptide shows promising potential as an anti-cancer agent and immune modulator, offering a targeted approach towards combating tumors.

2. Engineered T cells and uses therefor: Marlon's work with lipocalin muteins transduced into T cells presents an innovative strategy for enhancing therapeutic outcomes in patients. By utilizing lipocalin muteins specific to predetermined antigens, Marlon's research demonstrates superior target engagement and stability, paving the way for more effective treatments, especially in the realm of immunotherapy.

Career Highlights:

Marlon Hinner has contributed significantly to the field of biotechnology through his tenure at renowned companies such as Pieris Pharmaceuticals GmbH and Sanofi. His expertise and dedication have been instrumental in driving forward novel solutions for complex medical challenges.

Collaborations:

Throughout his career, Marlon has collaborated with esteemed professionals in the industry, including notable coworkers Andrea Allersdorfer and Alexander Wiedenmann. These collaborations have fostered a dynamic exchange of ideas and expertise, leading to transformative advancements in the biotechnology sector.

Conclusion:

Marlon Hinner's inventive spirit and unwavering commitment to scientific excellence underscore his impactful contributions to the realms of anti-cancer therapies and immunotherapy. His latest patents stand as a testament to his ingenuity and vision for a future where innovative medical solutions hold the key to combating challenging diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…